These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation. Gómez E, Laurés A, Baltar JM, Melón S, Díez B, de Oña M. Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530 [Abstract] [Full Text] [Related]
4. Cytomegalo and herpes simplex virus infections in renal transplant recipients. Wertheim P, Slaterus KW, Geelen JL, van der Noordaa J, Wilmink JM. Scand J Urol Nephrol Suppl; 1985 Nov; 92():5-8. PubMed ID: 3008317 [Abstract] [Full Text] [Related]
9. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients. Winston DJ, Ho WG, Bartoni K, Champlin RE. Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988 [Abstract] [Full Text] [Related]
10. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL. Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718 [Abstract] [Full Text] [Related]
12. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation. Weir MR, Henry ML, Blackmore M, Smith J, First MR, Irwin B, Shen S, Genemans G, Alexander JW, Corry RJ. Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352 [Abstract] [Full Text] [Related]
14. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients. Leroy F, Sechet A, Abou Ayache R, Thierry A, Belmouaz S, Desport E, Bauwens M, Bridoux F, Touchard G. Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080 [Abstract] [Full Text] [Related]
15. The transplanted kidney as a source of cytomegalovirus infection. Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA. N Engl J Med; 1975 Nov 27; 293(22):1109-12. PubMed ID: 171567 [Abstract] [Full Text] [Related]
16. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS. N Engl J Med; 1987 Oct 22; 317(17):1049-54. PubMed ID: 2821397 [Abstract] [Full Text] [Related]
18. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study. Moreno de la Higuera Díaz MA, Calvo Romero N, Sánchez-Fructuoso A, Conesa J, Marques Vidas M, Prats D, Barrientos Guzmán A. Transplant Proc; 2007 Sep 22; 39(7):2231-2. PubMed ID: 17889147 [Abstract] [Full Text] [Related]
19. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. Singh N, Dummer JS, Kusne S, Breinig MK, Armstrong JA, Makowka L, Starzl TE, Ho M. J Infect Dis; 1988 Jul 22; 158(1):124-31. PubMed ID: 2839576 [Abstract] [Full Text] [Related]